Get started
Author

Kerry Raynes

Observed names: K. Raynes, Raynes, Kerry
ORCID: 0000-0002-8493-3144
Observed ORCID: 0000-0002-8493-3144
OpenAlex ID: A5033752336
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19
2022 · Gavin D. Perkins, Chen Ji, et al. · JAMA · 414
PDF
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
2019 · Helena M Earl, Louise Hiller, et al. · The Lancet · 297
PDF
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
2019 · Mark T Drayson, Stella Bowcock, et al. · The Lancet Oncology · 172
PDF
Action video game training reduces the Simon Effect
2015 · Claire V. Hutchinson, Doug J. K. Barrett, et al. · Psychonomic Bulletin & Review · 41
PDF
Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT
2020 · Helena Earl, Louise Hiller, et al. · Health Technology Assessment · 21
PDF
Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients
2017 · Mark T Drayson, Stella Bowcock, et al. · Blood · 19
Remote Multicomponent Rehabilitation in Intensive Care Unit Survivors
2026 · Brenda O’Neill, Judy M. Bradley, et al. · JAMA · 12
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial
2020 · Catherine Atkin, Gulnaz Iqbal, et al. · British Journal of Haematology · 10
PDF
Remote multicomponent rehabilitation compared to standard care for survivors of critical illness after hospital discharge (iRehab): a protocol for a randomised controlled assessor-blind clinical and cost-effectiveness trial
2025 · Brenda O'Neill, Judy Martina Bradley, et al. · NIHR Open Research · 6
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT
2019 · Mark T Drayson, Stella Bowcock, et al. · Health Technology Assessment · 5
PDF
Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study
2020 · Ilaria J Chicca, Jennifer LJ Heaney, et al. · Efficacy and Mechanism Evaluation · 2
PDF
Ensuring participant safety in research studies evaluating digital mental health interventions delivered remotely - insights from the PIPA trial of an online parenting intervention to prevent affective disorders in high-risk adolescents
2026 · Jason Madan, Nicole De Valliere, et al. · BMC Medical Research Methodology · 1
Levofloxacin Prophylaxis in Newly Diagnosed Myeloma Patients
2019 · Mark Drayson, Stella Bowcock, et al. · SSRN Electronic Journal · 1
Optimising ethnic diversity in post intensive care rehabilitation research: strategies used in the iRehab trial
2026 · O'Neill, Brenda, Turtle, Beverley, et al. · Research Portal (Queen's University Belfast)
Remote Multicomponent Rehabilitation and Cost-Effectiveness in Survivors of Critical Illness
2026 · Mandana Zanganeh, Brenda O’Neill, et al. · JAMA Network Open
A randomised clinical trial to evaluate the clinical and cost-effectiveness of the use of synthetic tape during anterior cruciate ligament (ACL) reconstructive surgery
2026 · Kerry Raynes, Hema Mistry, et al. · http://isrctn.com/
An online Parenting Intervention to Prevent affective disorders in high-risk Adolescents: The PIPA Trial (Preprint)
2025 · Andrew Thompson, George Bouliotis, et al.
Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: The PERSEPHONE non-inferiority RCT
2020 · Helena Earl, Louise Hiller, et al. · Newcastle University ePrints (Newcastle Univesity)
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
2019 · Helena M. Earl, Louise Hiller, et al. · Newcastle University ePrints (Newcastle Univesity)
Major changes in levels of regulatory cytokines and functional antibodies contribute to severe immunodeficiency of myeloma patients and persist at one year post diagnosis
2018 · I. J. Chicca, J. L. J. Heaney, et al. · St George's Online Research Archive (St George's University of London)
PDF
Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients
2017 · Bowcock, Stella, Atkin, Catherine; id_orcid 0000-0003-0596-8515, et al. · University of Birmingham Research Portal (University of Birmingham)
Works count: 21
Citation count: 1,001
H-index: 8
I10-index: 8
Year
Topic
Type